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ABSTRACT Segregation of bacteria based on their metabolic activities in biofilms plays
an important role in the development of antibiotic resistance. Mushroom-shaped biofilm
structures, which are reported for many bacteria, exhibit topographically varying levels
of multiple drug resistance from the cap of the mushroom to its stalk. Understanding
the dynamics behind the formation of such structures can aid in design of drug delivery
systems, antibiotics, or physical systems for removal of biofilms. We explored the devel-
opment of metabolically heterogeneous Pseudomonas aeruginosa biofilms using numeri-
cal models and laboratory knockout experiments on wild-type and chemotaxis-deficient
mutants. We show that chemotactic processes dominate the transformation of slender
and hemispherical structures into mushroom structures with a signature cap. Cellular
Potts model simulation and experimental data provide evidence that accelerated move-
ment of bacteria along the periphery of the biofilm, due to nutrient cues, results in the
formation of mushroom structures and bacterial segregation. Multidrug resistance of
bacteria is one of the most threatening dangers to public health. Understanding the
mechanisms of the development of mushroom-shaped biofilms helps to identify the
multidrug-resistant regions. We decoded the dynamics of the structural evolution of
bacterial biofilms and the physics behind the formation of biofilm structures as well as
the biological triggers that produce them. Combining in vitro gene knockout experi-
ments with in silico models showed that chemotactic motility is one of the main driving
forces for the formation of stalks and caps. Our results provide physicists and biologists
with a new perspective on biofilm removal and eradication strategies.
KEYWORDS mushroom-shaped biofilm, cellular Potts model, chemotaxis,
Pseudomonas aeruginosa, antibiotic resistance, biofilms, cell motility, cell proliferation
Bacteria thrive in natural environments using two modes of growth, (i) planktonicgrowth by independent, single bacteria and (ii) biofilm growth, in which the cells
function as a group. Planktonic bacteria proliferate, infect hosts, and move without
much physical interaction with other bacteria in their vicinity. They are vulnerable to
antibiotics and to bacteriophages in their vicinity. In contrast, bacteria have evolved the
ability to aggregate together as biofilms to protect themselves from predators and
reduce the threats from antibiotics or toxic substances. Once a biofilm is established, it
can host billions of bacteria that function communally. However, bacterial cells within
a single biofilm exhibit different physiological states. They can be alive and active,
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alive and metabolically less active (dormant), or dead and decaying in different
parts inside the biofilm (1, 2). Some bacteria in biofilms are known to develop
resistance to multiple antibiotics (3, 4). For example, cells present at the top or cap
of mushroom-shaped biofilms have been shown to be resistant to colistin (5). Cells
within or on the stalk of mushroom-shaped biofilms, however, have shown resis-
tance to carbapenems and tobramycin (6). This suggests that it is impossible to
eliminate the entire mushroom structure using a single drug. Even worse, such
efforts could lead to selective killing of non-drug-resistant bacteria, leaving behind
the drug-resistant strains and accelerating the spread of an infection. In a few cases,
it has been shown that dormant bacteria are resistant to antibiotic treatments;
therefore, the segregation of bacteria into different states within the biofilm will
lead to differential drug resistance expression at different regions (7).
Recently, the World Health Organization (8) published a list of 12 bacteria which
could be of great threat to human health due to their multidrug resistance. Pseudomo-
nas aeruginosa has been identified as one of the bacteria of critical priority. P. aerugi-
nosa is known to form mushroom-shaped biofilm structures in nature and during
spaceflights (9). Cells in the interior of the mushroom-shape biofilm have low metabolic
activity, while the cells near the cap of the mushroom-shape biofilm have high
metabolic activity (10, 11). They can exhibit multidrug resistance within the same
mushroom structure as a consequence of these microcolonies harboring cells in
different metabolic states (12). Thus, due to the differences in physiological status
among the cells within the biofilm, it is difficult to eradicate the biofilm via drug
monotherapy. For example, colistin selectively kills less active cells (11, 13, 14), while
tobramycin kills highly active cells in the biofilm (15, 16). While some studies have
focused on microcolony formation, the mechanisms and dynamics of microcolony
formation are currently not well understood (17–20). If a mixture of two strains of P.
aeruginosa bacteria, e.g., a wild type with motility and a nonmotile mutant, are cultured
together, mushroom structures are formed with the wild-type motile bacteria on the
cap of the mushroom and the nonmotile mutants occupying the stalk of the mushroom
(19). Modeling studies have shown that bacterial motility plays a major role in deter-
mining the shape of the biofilm structure. Farrell et al. (21), developed a quasi-two-
dimensional force-based biofilm growth model to study the branching of biofilms
consisting of nonmotile bacteria. It was shown numerically that mechanical interactions
between the bacteria lead to the formation of two-dimensional (2D) finger-like biofilm
structures, which was previously thought to be an outcome of diffusion limitation. This
observation suggests that the macroscopic biofilm structure is actively changed by
microscopic interactions between individual bacteria and is not a passively evolved
structure due to nutrient gradients. However, extensive studies considering interaction
forces between the bacteria and nutrient limitations were unable to predict the
formation of the observed complex 3D mushroom shapes (21–25). Typically, these
studies predicted a series of hemispherical shapes but were not able to predict
the mushroom shapes observed in nature, specifically with those involving wild-type
bacteria. Here we report on the dynamics of biofilm shapes as they are influenced by
the availability of nutrients, the distribution of motile cells, and cell-cell interactions
through volume and chemotactic forces. Using laboratory experiments coupled with
in silico numerical studies, we identified the key parameters that determine the
thickness and height of the stalk as well as the cap of these macroscopic structures and
consequently the distribution of dormant and metabolically active bacteria. The laboratory
experiments, utilizing wild-type bacteria and specific mutants, were used to quantify and
validate the outcomes of the biofilm growth simulation model. We also show that che-
motactic processes dominate the transformation of slender and hemispherical structures to
mushroom structures with a signature cap.
Simulation model. Each bacterium in the simulation is considered a collection of
pixels. As the mass increases, the number of pixels for each cell increases proportionally
and the cells divide once the number of pixels has doubled. The cells’ mass increment
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is modeled using Tessier kinetics (26). We consider two nutrients, glucose and oxygen,
diffusing from the top of the simulation domain. Glucose is present in excess in both
the experiments and the numerical models. Single-solute Monod kinetics is the com-
mon choice in most biofilm models (25, 27–29). This, however, would result in expo-
nential cell growth in the simulations due to the presence of excess nutrients. Double-
solute Tessier kinetics models the bacterial mass increase in a more realistic way than
single-solute Monod kinetics by establishing a nutrient consumption rate that is
dependent on both limiting and excess nutrients, thereby preventing exponential cell
proliferation. It has been shown in previous studies that Tessier kinetics models the
growth of P. aeruginosa biofilms more accurately than Contois, Monod, or other
combined kinetics (26, 30). We have therefore developed two-substrate Tessier kinetics
for modeling the biofilm growth from uptake of oxygen and glucose (Table 1). Our
model based on Tessier kinetics is a more accurate predictor of the proliferation rate of
bacterial cells than are previous P. aeruginosa biofilm simulations (25, 27–29); the
proliferation rate is an important parameter for transformation of cells from an active
state to a dormant state.
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Equations 1 and 2 describe the time evolution of nutrient concentrations in the
simulation domain, and equations 3 and 4 quantify the rate of nutrient consumption by
the biomass. The equations are solved until steady state is reached, and the concen-
tration at steady state is used to estimate the mass increase through equation 7. The
motile bacteria can move through the domain between each time step of nutrient
estimation, which is 1 h. The motility of the cells is based on their energy constraint,
based on the Glazier-Graner-Hogeweg (GGH) model (31, 32) given by equation 8.
Motility is then dependent on the volume constraints, chemotaxis, and contact adhe-
sion between cells, substratum, and media. In the absence of volume increase and
TABLE 1 Summary of the values of different parameters used in the Tessier kinetics
model simulations
Parameter Valuea
Domain size 150  150  150 m
Initial mass of bacteria (27) 1.315  1013 g
Initial vol of bacteria (27) 27 m3
No. of initial bacteria 5 cells
Half-saturation coefficient of glucose (26) 26.9 g m3
Half-saturation coefficient of oxygen (26) 1.18 g m3
Boundary layer thickness (27) 16.5 m
Diffusion coefficient of glucose 2.52  106 m2 h1
Diffusion coefficient of oxygen 7.2  106 m2 h1
Maintenance coefficient for glucose (26) 0.0078 g gb1 h1
Maintenance coefficient for oxygen (26) 0.014 g gb1 h1
Specific growth rate (27) 0.29 h1
Yield coefficient of oxygen (26) 0.635
Yield coefficient of glucose (26) 0.628
Chemotaxis potential 400
Fluctuation amplitude term 40
Initial glucose concn 400 g m3
Initial oxygen concn 8 g m3
agb, gram biomass.
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chemotaxis, this motility corresponds to bacterial random walks as observed in nature
and is referred to as bacterial diffusion. The fluctuation amplitude term Tm (membrane
temperature) determines the average velocity of a random walk in the simulation. The
value of Tm is fixed in such a way that in the simulation the average distance moved by
a cell in 1 h due to bacterial diffusion falls within the average distance covered by P.
aeruginosa bacteria on a glass slide for 1 h in the experiments, which is around 145
m/h (33).
So and Sg are the concentrations of oxygen and glucose, respectively, Do and Dg are
the diffusion coefficients of oxygen and glucose, respectively,  is the cell growth rate,
and Bc is the biomass. The constants K, Y, and m are half-saturation, yield, and metabolic
coefficients, respectively, with their subscripts indicating the corresponding substrate,
oxygen or glucose. The mass increase as estimated by equation 7 is translated into a
corresponding target volume (VT) increase, calculated from the mass density of the
cells. The rate of volume increase or pixel addition to a cell is controlled by the change
in energy shown in equation 9. In a sparsely populated space, a bacterium will be
able to increase its volume faster than a bacterium in a densely packed space based on
the volume constraint constant. Bacteria in tightly packed configurations, however,
must push others toward the edge to increase their volume. Thus, the local energy
interactions for pixel space allocation will result in an overall change in the structure of
the biofilm. This energy interaction also prevents a cell from growing when there is no
space to place the additional biomass, thus avoiding unrealistic cell proliferation.
Therefore, the increase in biofilm biomass is controlled by nutrient consumption
kinetics and by structural energy constraints within the biofilm.
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The probability of a pixel copy (34) is calculated in equation 8. 	(i) is the pixel
occupied by the cell, Vcell is the volume of the cell, and  is the volume potential.
Equation 10 describes the contact adhesion energy between the cells of different types
, at positions i and j, where  is the Kronecker delta function and Con(	(i), 	(j)) is the
contact adhesion parameter. In the simulation, it is assumed that the cells are more
adherent to the substratum than to each other, meaning less local energy change for
adhering to the surface. The energy changes due to adhesion ΔEC and volume change
ΔEV are combined to evaluate the total energy change, ΔH  ΔEV  ΔEC.
RESULTS AND DISCUSSION
The simulations were carried out for 50 simulation hours. The change in structure of
the biofilm with time is summarized in Fig. 1. During the initial 20 h, the biofilm spreads
itself across the surface because of the minimal energy change through bacterium-
substratum contact. Later, when the nutrient concentration availability falls below the
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metabolic requirement of bacteria, the bacteria become dormant, indicated by the light
blue color in the simulation. Dormant bacteria in their natural habitat generally are
confined to their space without movement. In a similar way, dormant bacteria in the
simulation lose their motility and their consumption rate becomes negligible. These
processes add an extra layer to the growth segregation zone, the bottommost, no-
growth dormant zone. Therefore, as time progresses the zones vary in thickness and, as
expected, the final shape of the biofilm after 50 h was hemispherical. The preservation
of segregation zones during the entirety of the growth process is due to the moving
diffusion boundary layer and the increasing nutrient consumption rate at the dense
lower layers. Most models in the literature, including the forced-based model (21),
predict finger projection formation in 2D and simulate a hemisphere shape as shown
in Fig. 1, rather than the mushroom shape observed in laboratory experiments with
wild-type P. aeruginosa PAO1 bio1films (Fig. 2a). This indicates that some key mecha-
nisms are missing and the current model is not capable of simulating the dynamics of
mushroom shape formation. We performed experiments with a P. aeruginosa ΔbdlA
dispersion mutant. We characterized the structures with clearly distinguishable stalks
FIG 1 Simulated biofilm growth without chemotaxis. Shown are 3D views of the progress of biofilm
development at 10 h (a), 30 h (b), and 50 h (c) and a 2D x-z cross section at 50 h (d). Green indicates active
cells, and light blue indicates dormant cells.
FIG 2 Confocal images for different strains of P. aeruginosa biofilms after 3 days. (a) Wild-type PAO1; (b) ΔbdlA dispersion mutant; (c)
ΔcheY chemotaxis mutant. The scale bars are 20 m.
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and caps, at least 70 m tall, as mushroom-shaped biofilms. ΔbdlA mutants produce
mushroom shapes as shown in Fig. 2b, suggesting that the ability of bacteria to leave
the biofilm through active dispersal does not influence the formation of these mush-
room shapes and that the formation is inherent in all wild-type P. aeruginosa bacteria
irrespective of favorable or detrimental environmental cues.
As shown in Fig. 2, bdlA is not required for mushroom formation. Therefore, we carried
out experiments using a ΔcheY chemotaxis mutant. These mutant lacks chemotactic
motility, the motility associated with the directional movement of bacteria toward a
nutrient presence. The biofilms produced by this ΔcheY mutant did not produce mushroom
structures and instead formed large stalks without caps (Fig. 2c). This indicates a link
between mushroom structure and chemotactic motility. The simulation model was mod-
ified accordingly to include bacterial chemotaxis. This chemotactic parameter was subse-
quently included as an energy term, ΔE, coupled with the already existing contact adhesion
and volume constraint energy as ΔH  ΔEV  ΔEC  ΔE. The chemotactic energy potential
satisfies three conditions, as follows.
If the critical chemotaxis concentration is zero, then the change in energy potential
should be zero.
Csat → 0, E → 0 (11)
This condition biologically corresponds to the solute, which does not evoke che-
motaxis in cells, ergo the critical chemotaxis concentration is zero.
For solute concentrations below the critical concentration Csat, the change in energy
potential should be negative and chemotaxis should depend on the magnitude of the
gradient in concentration.
Csat  So i'→, E  0 (12)
If the critical concentration is very high, then the change in energy potential should
be minimum, which sets the cell to be always in motion along the gradient field with
the minimum chemotaxis potential, .
Csat → , E → min (13)











Equation 14 satisfies all three chemotaxis conditions and is used in the model to
implement chemotaxis based on oxygen concentration. As mentioned above, an
increase in volume of a cell in the simulation is modeled by increase in the number of
pixels associated with the cell. The newly added pixels of a growing cell are placed in
such a way that the local change in energy is minimized. Placing the new pixels along
the oxygen gradient decreases the chemotactic energy and consequently the local
energy change, thus favoring the cell growth along the nutrient gradient. It is expected
that the bacteria in the biofilm will grow or move toward the nutrient enriched zone
to sustain activity and biofilm growth. In the simulations, the motility is now a function
of contact adhesion, volume constraint, and chemotaxis. Simulations with this new
model with modified chemotaxis constraint produce mushroom shapes (Fig. 2). The
potential, chem, determines the “chemotaxis velocity,” the velocity at which the
bacteria move along the nutrient gradient. Higher chemotaxis velocity therefore thins
out the stalk of the mushroom.
The change of the height of the biofilm and the number of live cells with time is
shown in Fig. 3a. During the early stages of biofilm growth (20 to 30 h), the rate of
height increase is significantly lower than the proliferation rate. This is due to the
biofilm spreading across the substratum and covering a larger area, as was also observed
in experimental data for day 1 biofilm (Fig. 3d). After 35 h, the height of the biofilm
increases at a higher rate to accommodate the increase in total biomass. At the later stages
of biofilm growth, even though the proliferation rate decreases, the height of biofilm
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increases exponentially. The critical point in time (35 h) after which the height increases
exponentially is when the stalk of the mushroom starts to grow rapidly and a clear
distinction between the cap and stalk appears. This critical point can be better estimated
using the change in surface-to-volume ratio shown in Fig. 3b. After 35 h, the critical point,
the surface area of the biofilm increases rapidly, leading to the formation of a broad cap at
the top of mushroom. The spatial distribution of oxygen and the motility are shown in Fig.
4d and e, respectively. The cells at the bottom, which proliferate, must find a new space
FIG 3 (a) Change of biofilm height and cell count with time. (b) Change in surface-to-volume ratio of
the biofilm with time. (c and d) Simulation results showing the creation time (time at which a particular
cell appears in the simulation for the first time) of the bacterial cells at different layers within the
biofilm; the color key indicates the time of cell creation: 35 h (c) and 50 h (d). (e and f) Formation of
mushroom structure of PAO1 wild-type biofilm after 1 day (e) and 3 days (f). Green color indicates live
cells, red color indicates dead cells, and the white curve is a trace line on the outer surface of the
biofilm.
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which is energetically favorable. The energetically favorable outcome for the cell is to move
along the increasing nutrient gradient. In this GGH model with cell-cell adhesion energy, a
cell in a crowded environment needs to expend more energy to push the nearby cells to
move in its intended direction than does a cell in a sparsely populated environment. Due
to this inherent density-controlled cell motility, the model favors the mobility of cells in the
periphery of the biofilm.
Movement along the periphery of the microcolony is motion along the path of
least resistance to minimize the local energy and, consequently, the global energy.
As the cells in the periphery start to move upwards, the central width of the biofilm
begins to thin, and the stalk starts to form in the middle (Fig. 3d). The mature cells,
colored red in Fig. 3d, are found to climb over the relatively new cells at the stalk
and periphery guided by the chemotaxis gradient. Once the chemotaxis potential
has been maximized the motile cells start to aggregate into a crown at the top of
the biofilm; in other words, the cells have reached the region where oxygen is
available for survival. This process continues, and a clear distinction appears
between the cap and the stalk part of the mushroom shape.
The model simulations without chemotaxis (Fig. 1) and the experiments using the
chemotaxis-deficient ΔcheY mutant (Fig. 2c) did not produce any significant number of
mushroom shaped structures, as shown in Fig. 4f. This clearly shows that chemotaxis is
one of the key mechanisms in determining the shape of the biofilm. The formed
structures in ΔcheY biofilms closely resemble the hemispherical shape formed by the
contact and volume constraint version of the model. Segregation of bacteria within the
biofilm based on their metabolic activity is conclusive from the model. In the simula-
tions, three unique zones are observable in the formed mushroom structure: (i) the
dormant bottom layers, (ii) nutrient-limited layers of the stalk, and (iii) fast-proliferating
cells at the cap of mushroom. The bacteria in these three unique zones show differ-
FIG 4 Simulated biofilm growth with modified chemotaxis. (a to c) Shown are 2D section views of the progress of biofilm
development after 50 h at different chem values: 0.75 chem,fix (a), 1.0 chem,fix (b) and 1.25 chem,fix (c). Green indicates active cells, and
light blue indicates dormant cells. (d to f) Shown are the distribution of cell motility in the model simulation with chem being equal
to 1.25 chem,fix (d), distribution of oxygen concentration (e), and estimates of mushroom-shaped biofilm structures produced by
different strains used in the experiments (f).
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ential responses to antibiotics. Consequently, the entire biofilm becomes highly het-
erogeneous over time, similar to the observations made by Williamson et al. (35).
Therefore, eradication of the biofilm through clinical or chemical treatments is not
straightforward due to the various levels of antibiotic resistance at different layers of
the biofilm. This antibiotic resistance could arise due to the physiological heterogeneity
(35) of the cells or the accumulation of genetic mutations based on the local stresses
acting on the cells (36). Removing the cap and stalk of the mushroom will expose the
dormant cells to a fresh nutrient supply. This would help them revert to a metabolically
active state. In diseases, such as cystic fibrosis, involving P. aeruginosa biofilms, the
reversion of dormant bacteria to an active state could result in exacerbations leading
to acute infections (37). Our model can help us understand the time evolution of biofilm
structure in P. aeruginosa biofilms and, along with it, the spatial distribution of antibiotic
drug resistance. The model can be used to estimate antibiotic penetration and oxygen
limitations, which have been shown (38) to be contributors of antibiotic tolerance in P.
aeruginosa biofilms. Using model simulations to estimate the parameters, which could
otherwise be hard or impossible to measure experimentally, will aid a clinician in under-
standing the inherent heterogeneity and provide valuable decision-making insights into
selection of antibiotics. Additional development of the current model for other bacteria and
inclusion of drug-induced cell lysis mechanisms can establish the model as a predictor of
clinical efficacy of antibiotics.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains used in this study are listed in Table
2. P. aeruginosa strains were grown at 37°C in ABT minimal medium supplemented with 5 g liter1 of
glucose (ABTG) (39). Gentamicin (30 g ml1) or tetracycline (50 g ml1) was used as appropriate for
marker selection in P. aeruginosa.
Cultivation of biofilms in flow chambers. P. aeruginosa biofilms were cultivated in ABTG medium
at 37°C using 40-mm by 4-mm by 1-mm three-channel flow chambers as previously described (40).
Briefly, the bacterial strains were grown overnight in 2 ml of LB medium at 37°C with shaking (200 rpm).
The overnight cultures were diluted 1:100 with ABTG medium, and 300 l of the diluted culture was
injected via syringe and needle into each channel. The ABTG medium flow was halted for 1 h for
incubation of bacteria before resuming the flow at the rate of 4 ml h1 using a Cole-Parmer Masterflex
peristaltic pump (Cole-Parmer, United States) for development of biofilm. At each time point, 3.34 M
SYTO9 and 20 M propidium iodide (PI) stains (LIVE/DEAD BacLight bacterial viability kit; Invitrogen)
were injected into each channel to stain the biofilm for live and dead cell populations, respectively, for
15 min prior to confocal microscopy imaging. Experiments were performed in triplicate, and the
representative images are shown as results.
Confocal microscopy imaging. The stained biofilm was observed under confocal laser scanning
microscopy (CLSM) (LSM 780; Carl Zeiss, Germany), and images were acquired using either a 20 or 40
magnification objective lens. An argon laser (488 nm) and HeNe laser (561 nm) were used to observe the
green and red fluorescence, respectively. The captured images were further processed using IMARIS
software (Bitplane AG, Zurich, Switzerland) to generate the orthogonal view of the biofilm. Experiments
were performed in triplicate, and the representative images are shown as results.
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TABLE 2 Bacterial strains used in the experiments
Strains Characteristic(s)a Reference
PAO1 Wild type 41
ΔbdlA PW3587 bdlA-F03::ISlacZ/hah bdlA-deficient strain; Tcr 42
ΔcheY cheY-deficient strain; Gmr 43
aTcr, tetracycline resistant; Gmr, gentamicin resistant.
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